Doximity, Inc. (DOCS)

NYSE: DOCS · Real-Time Price · USD
72.37
-2.63 (-3.51%)
At close: Feb 21, 2025, 4:00 PM
71.52
-0.85 (-1.17%)
After-hours: Feb 21, 2025, 6:33 PM EST
-3.51%
Market Cap 13.58B
Revenue (ttm) 550.17M
Net Income (ttm) 201.35M
Shares Out 187.64M
EPS (ttm) 1.00
PE Ratio 72.34
Forward PE 53.59
Dividend n/a
Ex-Dividend Date n/a
Volume 3,202,510
Open 74.90
Previous Close 75.00
Day's Range 71.59 - 75.00
52-Week Range 22.96 - 85.21
Beta 1.39
Analysts Buy
Price Target 63.63 (-12.08%)
Earnings Date Feb 6, 2025

About DOCS

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manuf... [Read more]

Sector Healthcare
IPO Date Jun 24, 2021
Employees 827
Stock Exchange NYSE
Ticker Symbol DOCS
Full Company Profile

Financial Performance

In 2023, Doximity's revenue was $475.42 million, an increase of 13.45% compared to the previous year's $419.05 million. Earnings were $147.58 million, an increase of 30.81%.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price forecast is $63.63, which is a decrease of -12.08% from the latest price.

Price Target
$63.63
(-12.08% downside)
Analyst Consensus: Buy
Stock Forecasts

News

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. ...

15 hours ago - Business Wire

Doximity: Rating Downgrade As Near-Term Upside Is Priced In

I downgraded Doximity from buy to hold due to expected growth slowdown and current high valuation at 40.5x forward EBITDA. DOCS reported strong Q3 performance with $168.6 million revenue, 25% y/y grow...

7 days ago - Seeking Alpha

Doximity Momentum, Big Money Support Stays Strong

Shares of Doximity, Inc. (DOCS) jump on business growth, investor inflows.

7 days ago - FXEmpire

Doximity to Participate in the Raymond James 46th Annual Institutional Investors Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th ...

8 days ago - Business Wire

Doximity Q3 Earnings: Outpacing Even Management's Expectations

I previously rated Doximity, Inc. a buy due to strong Q2 earnings, favorable DCF analysis, and its strategic position in the healthcare industry. Q3 earnings showed continued strength, with DOCS stock...

11 days ago - Seeking Alpha

Digital Health Platform Doximity Stock Jumps On Upbeat Annual Outlook, Analysts Raise Forecast

Doximity Inc DOCS stock is trading higher on Friday after the company reported third-quarter fiscal 2025 results that beat analysts' expectations and upbeat guidance.

14 days ago - Benzinga

Doximity shares pop 30% on revenue beat, rosy guidance

Doximity shares ripped higher Friday, a day after reporting fiscal third-quarter results that beat expectations for revenue and guidance. Analysts called it a "statement type of quarter" for the compa...

14 days ago - CNBC

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

15 days ago - Seeking Alpha

Doximity shares soar 21% after company beats on revenue, raises fiscal year guidance

Doximity reported third-quarter fiscal 2025 results that beat analysts' expectations for revenue and guidance. The company's revenue increased 25% to $168.6 million in its third quarter.

15 days ago - CNBC

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fourth Consecutive Year

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the V...

15 days ago - Business Wire

Doximity Announces Fiscal 2025 Third Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 20...

15 days ago - Business Wire

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter e...

5 weeks ago - Business Wire

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

Upgraded Doximity to a buy rating due to recent share price pullback, stronger engagement metrics, and deeper client relationships, creating a compelling entry point. DOCS reported 20% y/y revenue gro...

5 weeks ago - Seeking Alpha

Stock Picks From Seeking Alpha's December 2024 New Analysts

In December, we welcomed 29 new analysts to Seeking Alpha and in this article we are showcasing their stock picks and investment strategies. Five buy picks are highlighted on Viasat, Newmont, NeuroOne...

Other symbols: ALGMCECEGETDFDVVFSSHOG
6 weeks ago - Seeking Alpha

Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown

It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health com...

2 months ago - CNBC

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician...

2 months ago - Business Wire

Doximity: Strong Fundamentals And Growth Potential Makes It Attractive

Doximity's dominance in digital healthcare is evident with over 80% of U.S. doctors using the platform, driving strong network effects and competitive positioning. The company boasts impressive financ...

2 months ago - Seeking Alpha

Doximity Q2 Earnings: Positioning Is Paying Off

I rate Doximity a buy with a price target of $65, reflecting a 24% upside due to strong Q2 earnings and favorable industry trends. Doximity's Q2 earnings showed impressive revenue growth, margin expan...

3 months ago - Seeking Alpha

Why Doximity Stock is Set to Open at Highest Point in Over 2 Years Friday

Doximity (DOCS) shares jumped nearly 40% in premarket trading Friday after the medical tech company's earnings and outlook came in above what analysts expected.

3 months ago - Investopedia

Doximity Stock Soars 42% Toward Best Day Ever. It's Not the Only Record.

The online medical platform reported quarterly revenue of $136.8 million and earnings of 30 cents a share, beating analysts expectations.

3 months ago - Barrons

Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript

Doximity, Inc. (NYSE:DOCS) Q2 2025 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Perry Gold - Vice President of Investor Relations Jeff Tangney - Co-Founder and CEO Anna B...

3 months ago - Seeking Alpha

Doximity Announces Fiscal 2025 Second Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, ...

3 months ago - Business Wire

Doximity to Present at the Jefferies London Healthcare Conference

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and An...

4 months ago - Business Wire

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...

4 months ago - Business Wire

Overlooked Stock: DOCS

Doximity (DOCS) is trading near its 52-week high after getting an upgrade from Barclays. George Tsilis talks about why the "LinkedIn for physicians" can be gaining investor interest.

4 months ago - Schwab Network